NASDAQ · Biotechnology

Creative Medical Technology Holdings, Inc. (CELZ) Stock

$0.84 -2.55% NASDAQ: CELZ Healthcare

Valuation

MetricValue
Price$0.84
Market Cap$2.16M
P/E Ratio-0.47
P/B Ratio0.40
P/S Ratio810.50
EPS (TTM)$-1.43
52-Week High$6.25
52-Week Low$0.62
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-86.70%
ROA-64.42%
ROCE-71.90%
Gross Margin-39.87%
Operating Margin-1980.50%
Net Margin-1920.66%
Debt/Equity0.00
Current Ratio19.69

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-10.0M$-6.0M$-6.0M$-6.0M
Net Profit$19.0M$-10.0M$-5.0M$-5.0M$-6.0M
EPS$56.10$-9.28$-3.76$-3.71$-2.52
Op Margin-3562.2%-11562.5%-62445.9%-52216.9%-102380.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$11.0M$19.0M$11.0M$7.0M$8.0M
Total Liabilities$1.0M$3.0M$0$0$0
Cash$11.0M$8.0M$3.0M$6.0M$7.0M
Borrowings$0$0$0$0$0

Latest News

Creative Medical Technology Holdings Issues Mid-Year Update GlobeNewswire · Jul 1, 2026 Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds GlobeNewswire · Jun 30, 2026 These Three Stocks Fell More Than 10% Today To Hit 52-Week Lows -- What's Driving The Investor Skepticism? Stocktwits · Jun 26, 2026 Top Premarket Decliners MT Newswires · Jun 26, 2026 Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain GlobeNewswire · Jun 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-8.0M$-8.0M$-5.0M$-6.0M
Investing Cash Flow$0$-10.0M$3.0M$6.0M$0
Financing Cash Flow$-1.0M$0$0$0$0
Net Cash Flow$11.0M$-2.0M$-5.0M$2.0M$1.0M
Free Cash Flow$-2.0M$-8.0M$-8.0M$-5.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA1.03
FCF Yield-242.72%
Quick Ratio12.73
Interest Coverage0.00
Return 1Y-67.25%
Return 3Y-83.29%
Return 5Y-99.48%

Ownership

Insiders Held0.74%
Institutions Held5.07%
Institutions Float Held5.10%
Institutional HolderSharesReport Date
Geode Capital Management, LLC38,2902026-03-31
Vanguard Capital Management LLC20,3502026-03-31
Xtx Topco Ltd14,2602026-03-31
Susquehanna International Group, LLP10,4692026-03-31
Global Retirement Partners, LLC7,9182025-12-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc. is led by CEO Timothy Warbington, employs 4 people, headquartered in US, publicly traded since 2015.

Creative Medical Technology Holdings, Inc. (CELZ) stock trades at $0.84 with a market capitalization of $2.16M. The stock is valued at a price-to-earnings (P/E) ratio of -0.47, price-to-book of 0.40, price-to-sales of 810.50. Over the past 52 weeks the stock has ranged between $0.62 and $6.25, and currently trades 86.6% below its 52-week high.

On profitability, Creative Medical Technology Holdings, Inc. generates a return on equity (ROE) of -86.70%, return on capital employed of -71.90%, an operating margin of -1980.50%, a net profit margin of -1920.66%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides